Isolated regional perfusion; anaesthetic technique, monitoring and blood replacement
- PMID: 6498570
- DOI: 10.1007/BF03009542
Isolated regional perfusion; anaesthetic technique, monitoring and blood replacement
Abstract
Isolated regional perfusion for the treatment of malignant melanoma is an accepted method of treatment. No standard of anaesthetic practice has been established for those individuals. Perioperative records of patients undergoing isolated limb perfusion were studied to determine adequate blood replacement. Records were examined and compared for (1) age, (2) ASA physical status, (3) presence of associated disease, (4) anaesthetic technique, (5) the amount of blood and fluid replacement, (6) preoperative haemoglobin (hgb) and haematocrit (hct) and postoperative serial complete blood counts. Fifteen patients were studied (mean age 53 +/- 16 yrs). Mean blood and fluid replacement was: packed red blood cells; 2.28 +/- 0.82 units, 722 +/- 17 ml of 5 per cent albumin, 1747 +/- 21 ml crystalloid. There were twelve Physical Status Class I or II and three Class III patients. All patients received general anaesthesia. There was a statistically significant difference in the preoperative and postoperative values for haemoglobin and haematocrit (p less than 0.01) with no difference between the postoperative and discharge values. Adequate blood replacement was determined by the equation: (Formula: see text) Extensive invasive monitoring is not routinely required for adequate blood replacement or the detection of leaks between the systemic and isolated circulation.
Similar articles
-
Isolated limb perfusion with melphalan in the treatment of malignant melanoma.Br J Surg. 1980 Sep;67(9):660-2. doi: 10.1002/bjs.1800670919. Br J Surg. 1980. PMID: 7427069
-
Systemic and haemodynamic toxicity after isolated limb perfusion (ILP) with TNF-alpha.J Exp Clin Cancer Res. 2004 Jun;23(2):225-31. J Exp Clin Cancer Res. 2004. PMID: 15354406
-
A clinical and pharmacokinetic study of isolated limb perfusion with heat and melphalan for melanoma.Cancer. 1985 Jun 1;55(11):2638-44. doi: 10.1002/1097-0142(19850601)55:11<2638::aid-cncr2820551118>3.0.co;2-e. Cancer. 1985. PMID: 3995475
-
Isolated limb perfusion for melanoma: effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs.World J Surg. 1992 Mar-Apr;16(2):227-33. doi: 10.1007/BF02071525. World J Surg. 1992. PMID: 1561803 Review.
-
Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion.J Surg Oncol. 2011 Sep;104(4):397-404. doi: 10.1002/jso.22028. J Surg Oncol. 2011. PMID: 21858835 Review.
Cited by
-
The Use of Regional Anesthesia to Reduce Blood Loss in Isolated Limb Perfusion (ILP)-A Novel Approach.J Clin Med. 2023 Oct 16;12(20):6542. doi: 10.3390/jcm12206542. J Clin Med. 2023. PMID: 37892681 Free PMC article.
-
Continuous intraoperative external monitoring of perfusate leak using iodine-131 human serum albumin during isolated perfusion of the liver and limbs.Eur J Nucl Med. 1995 Nov;22(11):1242-8. doi: 10.1007/BF00801607. Eur J Nucl Med. 1995. PMID: 8575471
-
Anesthesia management of patients undergoing hyperthermic isolated limb perfusion with melphalan for melanoma treatment: an analysis of 17 cases.BMC Anesthesiol. 2013 Jul 17;13(1):15. doi: 10.1186/1471-2253-13-15. BMC Anesthesiol. 2013. PMID: 23865420 Free PMC article.
-
Multidisciplinary Perioperative Management of Hyperthermic-Isolated Limb Perfusion for Malignant Melanoma: A Case Report.Indian J Surg Oncol. 2021 Dec;12(Suppl 2):371-373. doi: 10.1007/s13193-021-01371-z. Epub 2021 Aug 3. Indian J Surg Oncol. 2021. PMID: 35035175 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Medical